|
|
|
Volumn 35, Issue 5, 2008, Pages 745-752
|
|
Recent advances in molecular-targeted drugs in head and neck cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MONOCLONAL ANTIBODY;
DRUG ANTAGONISM;
HEAD AND NECK TUMOR;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SQUAMOUS CELL CARCINOMA;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SQUAMOUS CELL;
HEAD AND NECK NEOPLASMS;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 45549108897
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (48)
|
